Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

Ty is an experienced writer, editor, journalist, and online opinion-haver. He has been reviewing cars and covering automotive news full-time for nearly a decade for outlets such as Gear Patrol, Inside ...

Horsepower may be the automotive industry’s most important metric. Typically, horsepower is the first spec listed on a manufacturer’s website, the first number people look at, and the figure that ...

Artificial Intelligence (AI) has achieved remarkable successes in recent years. It can defeat human champions in games like Go, predict protein structures with high accuracy, and perform complex tasks ...

As language models (LMs) improve at tasks like image generation, trivia questions, and simple math, you might think that human-like reasoning is ...

Artificial intelligence has become almost impossible to avoid, and for many, it's slowly replacing Google and other search engines. But while ChatGPT and its competitors can be useful, it's important ...